Emergent BioSolutions Inc. Quarterly Goodwill in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Emergent BioSolutions Inc. quarterly Goodwill history and growth rate from Q4 2010 to Q2 2024.
  • Emergent BioSolutions Inc. Goodwill for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0 -$218M -100% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $0 -$218M -100% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $0 -$218M -100% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $0 -$225M -100% Sep 30, 2023 10-Q 2023-12-11
Q2 2023 $218M -$6.7M -2.98% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $218M -$6.7M -2.98% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $218M -$6.7M -2.98% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $225M -$41.6M -15.6% Sep 30, 2022 10-Q 2023-12-11
Q2 2022 $225M -$41.7M -15.6% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $225M -$41.6M -15.6% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $225M -$41.8M -15.7% Dec 31, 2021 10-K 2024-03-08
Q3 2021 $267M $0 0% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $267M +$300K +0.11% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $267M +$100K +0.04% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $267M +$100K +0.04% Dec 31, 2020 10-K/A 2023-12-11
Q3 2020 $267M -$2.1M -0.78% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $266M -$2M -0.75% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $266M -$1.3M -0.49% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $267M +$6.9M +2.66% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $269M +$219M +447% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $268M +$219M +446% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $268M +$219M +445% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $260M +$211M +429% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $49.1M +$8.13M +19.8% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $49.1M +$8.13M +19.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $49.1M +$8.13M +19.8% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $49.1M +$8.1M +19.8% Dec 31, 2017 10-K 2019-02-22
Q3 2017 $41M $0 0% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $41M -$13.9M -25.3% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $41M -$13.9M -25.3% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $41M $0 0% Dec 31, 2016 10-K 2018-02-23
Q3 2016 $41M -$11.6M -22% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $54.9M +$2.32M +4.41% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $54.9M +$12.9M +30.8% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $41M -$11.6M -22% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $52.6M +$11.3M +27.3% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $52.6M +$5.4M +11.4% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $42M -$5.2M -11% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $52.6M +$38.6M +277% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $41.3M +$27M +189% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $47.2M +$41.7M +758% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $47.2M +$41.7M +758% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $14M +$8.45M +154% Dec 31, 2013 10-K 2016-02-29
Q3 2013 $14.3M +$8.79M +160% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $5.5M $0 0% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $5.5M $0 0% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $5.5M $0 0% Dec 31, 2012 10-K/A 2015-03-09
Q3 2012 $5.5M $0 0% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $5.5M +$473K +9.41% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 $5.5M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $5.5M $0 0% Dec 31, 2011 10-K 2014-03-10
Q3 2011 $5.5M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $5.03M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 $5.5M Dec 31, 2010 10-K 2013-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.